PROGRAMME 2018-11-21T14:52:01+00:00

Rikli Balance Hotel, Bled, Slovenija, November 22nd – November 24th 2018

PROGRAMME



THURSDAY, 22nd NOVEMBER 2018

Registration opens at 10:00 am


 12:00 am – 12:30 am – Male hypogonadism – Plenary lecture (Chair: Tadej Battelino)

  • Testosterone replacement therapy – new insights into risks and benefits (Marija Pfeifer)

12:30 am – 1:00 pm – Diabetes and kidney – Plenary lecture (Chair: Draženka Pongrac Barlovič)

  • Diabetic nephropathy – established paradigms and novel insights (Per-Henrik Groop, Finland)

1:00 pm – 2:00 pm Lunch


2:00 pm – 2:30 pm – Satellite symposium

2:30 pm – 3:00pm – Satellite symposium

3:00 pm – 3:40 pm – Pathophysiology of diabetes – new insights (Chairperson: Vilma Urbančič Rovan)

  • Diabetes – from skeletal muscle perspective (Sergej Pirkmajer)
  • Pathogenesis of diabetic cerebral microangiopathy (Fajko F. Bajrović)

3:40 pm – 4:40 pm – Pituitary (Chairperson: Marija Pfeifer)

  • Genetics of pituitary tumours (Donato Iacovazzo, UK)
  • Craniopharyngiomas in Slovenian population (Primož Kotnik, Mojca Jensterle Sever)
  • Management of prolactinomas during pregnancy (Katarina Mlekuš Kozamernik)

4:40 pm – 5:10 pm Coffee break


5:10 pm – 6:00 pm – Congress Opening

  • Mahkota Award Ceremony

 6:00 pm – 6:30 pm – Gene therapy – Plenary lecture (Chairperson: Tadej Battelino)

  • Gene therapy for adrenoleukodystrophy (Florian Eichler, USA)

 6:30 pm – 7:05 pm – Satellite symposium


 8:00 pm – 09:30 – Welcome reception


.

FRIDAY, 23rd NOVEMBER 2018

8:00 am – 9:00 am – Satellite symposium

9:00 am – 10:00 am – Use of modern technologies in the treatment of diabetes (Chairpersons: Tadej Battelino, Nadan Gregorič)

  • …during pregnancy (Marjeta Tomažič)
  • …in adults (Aleš Skvarča)
  • Time in range(s) – TIRs – new clinical reality (Tadej Battelino)

10:00 am – 11:00 am – Thyroid (Chairperson: Edvard Pirnat)

  • Diagnostics of Graves’ disease (Katja Zaletel, Edvard Pirnat)
  • Treatment of Graves’ disease (Simona Gaberšček, Nataša Bedernjak Bajuk, Katica Bajuk Studen)
  • Graves’ orbitopathy (Polona Jaki Mekjavić)
  • Radioiodine treatment in patients with Graves’ orbitopathy (Daša Šfiligoj, Polona Jaki Mekjavić, Simona Gaberšček)

11:00 am – 11:30 am – Coffee break


 11:30 am – 12:00 pm – Osteoporosis – Plenary lecture (Chairperson: Tomaž Kocjan)

  • Long term treatment of osteoporosis (Serge Ferrari, Switzerland)

 12:00 pm – 1:00 pm – Fatty liver disease (Chairpersons: Draženka Pongrac Barlovič, Simona Ferjan)

  • NAFLD in patients with diabetes (Špela Volčanšek)
  • Treatment of NAFLD (Draženka Pongrac Barlovič)
  • NAFLD in patients with PCOS (Djuro Macut, Serbia)

1:00 pm – 1:45 pm – Lunch


1:45 pm – 2:45 pm – Satellite symposium

2:45 pm– 3:15 pm – Insulin therapy – Plenary lecture (Chairperson: Andrej Janež)

  • Modern therapy in type 2 diabetes (Chantal Mathieu, Belgium)

3:15 pm – 4:30 pm – Reproductive endocrinology (Chairpersons: Mojca Jensterle Sever, Marija Pfeifer)

  • Gut-brain axis and metabolism in PCOS (Bulent O. Yildiz, Turkey)
  • Incretin system as a new treatment target in PCOS patients with high metabolic risk (Mojca Jensterle Sever, Andrej Janež)
  • Patient tailored approach to treatment for different PCOS phenotypes (Evanthia Diamanti-Kandarakis, Greece)

4:30 pm – 5:00 pm   Coffee break


5:00 pm –6:00 pm – Bone and calcium (Chairpersons: Andrej Zavratnik, Antonela Sabati Rajić)

  • New treatments for hypoparathyroidism (Andrea Palermo, Italy)
  • Iatrogenic hypocalcaemia after treatment with antiresorptive drugs (Andrej Zavratnik)
  • Management of bone disease in primary hyperparathyroidism (Tomaž Kocjan)

6:00 pm – 7:30 pm – Satellite symposium


8:00 pm – 10:00 pm – Congress dinner


.

SATURDAY 24th NOVEMBER 2018

8:00 am – 9:00 am – Satellite symposium 

9:00 am – 10:30 am – Oral presentations (Chairpersons: Katica Bajuk Studen, Aleš Skvarča)


10:30 am – 11:00 am   Coffee break


11:00 am – 11:45 am – Inborn errors of metabolism (Chairpersons: Mojca Žerjav Tanšek, Marjeta Tomažič)

  • Broadened screening for inborn errors of metabolism (Urh Grošelj)
  • Management of inborn errors of metabolism in our region (Mojca Žerjav Tanšek)
  • Transition of patients with inborn errors of metabolism from paediatric to adult endocrinologist (Nadan Gregorič)

11:45 am – 1:15 pm – Adrenal (Chairperson: Tomaž Kocjan)

  • Dynamic testing of the HPA axis (Eystein Husebye, Norway)
  • Cushing’s vs. pseudo-Cushing’s syndrome (Karim Meeran, UK)
  • Management of patients with adrenocortical carcinoma (Darko Kaštelan, Croatia)

1:15 am – 1:35 pm – Pathophysiology of diabetes – new insights (Chairperson: Vilma Urbančič Rovan)

  • Key role of beta cells in normal and pathologic homeostasis of energy rich molecules (Andraž Stožer)

1:35 pm – 2:35 pm – Diabetes and vascular disease (Chairperson: Mišo Šabovič)

  • Assessment of arterial function in patients with diabetes (Miodrag Janić)
  • Pharmacological options to improve arterial function in patients with type 1 diabetes (Mojca Lunder)
  • Genetic markers of atherosclerosis progression in patients with type 2 diabetes (Aleš Pleskovič)

2:35 pm – Congress closing

  • Award ceremony and snacks


PROGRAMME of Satellite Symposia


THURSDAY, 22nd NOVEMBER 2018

2:00 pm – 2:30 pm – Eli Lilly (Chairperson: Vilma Urbančič Rovan)

  • Dulaglutide – overview of new clinical data from the AWARD programme. (Draženka Pongrac Barlovič)

2:30 pm – 3:00 pm Amgen (Chairperson: Tomaž Kocjan)

  • Effects of denosumab in glucocorticoid treated patients (Serge Ferrari)

6:30 pm – 7:05 pm – Novartis (Chairperson: Tomaž Kocjan)

  • Novartis Pharma: Paradigm shift in the management of chronic heart failure with diminished ejection fraction (Gregor Poglajen)
  • Lek: Role of zoledronic acid in the modern management of osteoporosis (Tomaž Kocjan)

FRIDAY, 23rd NOVEMBER 2018

8:00 am – 9:00 am – Astra Zeneca (Chairperson: Andrej Janež)

  • Morning debate on therapy with SGLT2 inhibitors: when to begin and what to expect? (Thomas Forst and Andrej Janež)

1:45 pm – 2:45 pm – Boehringer – Ingelheim (Chairperson: Marko Gričar)

  • Type 2 Diabetes – fulfilling the desire to know more and do better
    • The diabetologist’s perspective (Andrej Janež)
    • The cardiologist’s perspective (Bojan Vrtovec)
    • The nephrologist’s perspective (Andreja Marn)

6:00 pm – 7:30 pm – Novo Nordisk (Chairperson: Andrej Janež)

  • Introduction to the symposium: What are important outcomes in diabetes treatment? (Andrej Janež)
  • Cardiologist’s view on the treatment of type 2 diabetes (Zlatko Fras)
  • GLP-1 RA – Known and unknown effects beyond glucose control (Simona Ferjan)
  • What is next in the area of GLP-1 RA? (Chantal Matthieu)
  • How to reach important outcomes with once daily fixed dose optimization? (Aleš Skvarča)
  • How to reach important outcomes with new even faster prandial insulin? (Andrej Zavratnik)

SATURDAY, 24th NOVEMBER 2018

8:00 am – 9:00 am – Sanofi (Chairperson: Andrej Janež)

  • New fixed combination of basal insulin glargine and GLP1 RA lixisenatide: efficacy through synergy (Brath Helmut)
  • Practical considerations when using fixed ratio combination of insulin glargine and lixisenatide (Vilma Urbančič Rovan)


FREE COMUNICATIONS


ORALS

MKRN3 GENE MUTATIONS IN FAMILIAL AND SPORADIC PATIENTS WITH CENTRAL PRECOCIOUS PUBERTY (Magdalena Avbelj Stefanija, Jernej Kovač, Eva Kladnik, Galia Yablonski, Alma Toromanović, Gordana Stipančič, Tatjana Milenković, Aleksandra Jančevska, Vera Zdravković, Maja Jesić, Rade Vuković, Sandra Stanković, Slađana Todorović, Tinka Hovnik, Moshe Phillip, Tadej Battelino, Liat De Vries)

TESTOSTERONE REPLACEMENT THERAPY IN OBESE HYPOGONADAL MEN WITH TYPE 2 DIABETES (Kristina Groti Antonič)

VEČLETNO ZDRAVLJENJE BOLNIKOV S SLADKORNO BOLEZNIJO TIPA 1 Z INZULINSKO ČRPALKO V SPLOŠNI BOLNIŠNICI JESENICE (Karmen Janša)

TSH LEVELS IN CHILDREN WITH FAMILIAL AND WITH POLYGENIC HYPERCHOLESTEROLEMIA (Matej Mlinarič, Tadej Battelino, Urh Grošelj)

ENDOCRINE PROFILE OF HEART TRANSPLANT RECIPIENTS IN AN EARLY POST-TRANSPLANT PERIOD (Matej Rakuša, Bojan Vrtovec, Gregor Poglajen, Andrej Janež, Mojca Jensterle Sever)

QUALITY OF LIFE AND DEPRESSION IN PATIENTS WITH ADRENAL INCIDENTALOMAS (Antoan Stefan Sojat, Ljiljana Marina, Miomira Ivovic, Milina Tancic-Gajic, Zorana Arizanovic, Srdjan Pandurevic, Nevena Radonjic, Bojana Dunjic, Andja Cirkovic, Aleksandra Kendereski, Svetlana Vujovic)

THE IMPACT OF ACUTE HYPERGLYCAEMIA ON THE ACTIVATION OF COGNITIVE AREAS IN THE BRAIN (Jasna Šuput Omladič, Nataša Bratina, Andrej Vovk, Anka Slana Ozimič, Grega Repovš, Simona Klemenčič, Magdalena Avbelj Stefanija, Tadej Battelino)

PATTERNS OF GLUCOSE CONCENTRATION AND INSULIN SECRETION DURING A 5H OGTT IN PATIENTS WITH NON-DIABETIC HYPOGLYCAEMIA (Špela Volčanšek, Mojca Lunder, Urška Perc, Urban Kugonič, Draženka Pongrac Barlovič)


POSTERS – Endocrinology

SUCCESSFUL TREATMENT OF PHEOCHROMOCYTOMA CRISIS EMERGENCY SURGERY: A CASE REPORT (Valentina Ahac, Igor Mark, Klemen Steblovnik, Kristina Groti Antonič, Igor Sterle, Tomaž Kocjan)

ECHINOCOCCAL CYST AS A CAUSE OF INCREASED LUMBAR BONE MINERAL DENSITY – LONG-TERM MONITORING (Miro Čokolič, Urška Kšela)

INSULINOM: PRIKAZ TREH PRIMEROV (2017-2018) (Mitja Krajnc, Urša Kšela)

PATHWAYS AND DEAD ENDS IN THE DIAGNOSIS AND MANAGEMENT OF CUSHING’S SYNDROME (Tina Krokter Kogoj, Katarina Mlekuš Kozamernik, Mojca Jensterle Sever, Kristina Groti Antonič, Antonela Sabati Rajić, Miro Čokolič, Tomaž Kocjan)

TAKOTSUBO SYNDROME IN A PATIENT WITH AN ADRENAL INCIDENTALOMA AND AUTONOMOUS CORTISOL SECRETION (Ljiljana Marina, Miomira Ivovic, Milan Dobric, Milan Marinkovic, Milina Tancic-Gajic, Zorana Arizanovic, Aleksandra Kendereski)

CASE REPORT: SEVERE HYPERCALCEMIA DUE TO PRIMARY HYPERPARATHYROIDISM RESULTING IN MULTIORGAN FAILURE (Maja Navodnik Preložnik, Aleksandra Šauperl)

INSULIN RESISTANCE AND MENOPAUSE (Srđan Pandurević, Ljiljana Marina, Miomira Ivović, Milina Tančić-Gajić, Zorana Arizanović, Jelena Milin-Lazović, Aleksandra Kendereški, Svetlana Vujović)

GNRHR LOSS-OF-FUNCTION MUTATIONS IN A PATIENT WITH SPONTANEOUS RECOVERY OF CENTRAL HYPOGONADISM (Darja Šmigoc Schweiger, Katarina Trebušak Podkrajšek, Jasna Šuput Omladič, Primož Kotnik, Tadej Battelino, Magdalena Avbelj Stefanija)

VZTRAJEN PORAST KROMOGRANINA, A BREZ DOKAZA NEVROENDOKRINEGA TUMORJA (Matej Završnik)


POSTERS – Diabetes

LOWER LIMB AMPUTATION IN DIABETIC PATIENTS AT UMC MARIBOR (SLOVENIA) IN A NINE-YEAR PERIOD (2009-2017) (Miro Čokolič)

PSYCHOLOGICAL FACTORS IN PATIENTS WITH NON-DIABETIC HYPOGLYCAEMIA (Nina Erjavec, Urška Perc, Urban Kugonič, Draženka Pongrac Barlovič)

COMBINATION OF ANTIDIABETIC AGENTS PROVIDES BETTER ALTERNATIVE THAN INSULIN MONOTHERAPY FOR A PATIENT WITH HIGH INSULIN RESISTANCE (Nadan Gregorič, Maja Ravnik Oblak)

CLINICAL PRESENTATIONS OF ADULT NON-DIABETIC HYPOGLYCEMIC DISORDERS IN DIABETES OUTPATIENT CLINIC IN LJUBLJANA (Mojca Lunder, Špela Volčanšek, Urška Perc, Urban Kugonič, Draženka Pongrac Barlovič)

KAJ SE LAHKO SKRIVA ZA STOPALNO RAZJEDO? (Iris Marolt, Slavica Mankoč)

THE IMPACT OF LOW-CARB HIGH-FAT DIET ON A METABOLIC CONTROL IN AN OBESE TYPE 1 DIABETIC PATIENT WITH POLYCYSTIC OVARY SYNDROME (Aleš Skvarča, Katarina Peklaj)

PRIPOROČILA ZA OPTIMIZACIJO OBRAVNAVE BOLNIKA S SLADKORNO BOLEZNIJO TIPA 2 V POMURJU (Zorancho Trpkovski, Rudolf Mikolič, Zdenka Tratnjek, Tadeja Gašparič Pincetić, Angela Ambrož, Alenka Kovačič, Joža Primožič, Simona Šilec, Vanja Lutar, Suzana Maučec, Valerija Hozjan, Dominik Černi)

AGE IS NOT A BARRIER TO INSULIN PUMP (CSII) THERAPY: A CASE PRESENTATION OF AN ELDERLY PATIENT’S SUCCESSFUL DIABETES MANAGEMENT (Špela Volčanšek, Mojca Lunder, Andrej Janež)

ADD-ON GLP1 RECEPTOR AGONISTS OR SGLT 2 INHIBITORS CAN IMPROVE CARDIOMETABOLIC OUTCOMES IN PEOPLE WITH TYPE 2 DIABETES: DATA FROM EVERYDAY PRACTICE (Katarina Vukelič, Andrej Juretič)